Jeffrey E. Jacob - 12 Sep 2023 Form 4 Insider Report for Panbela Therapeutics, Inc. (PBLA)

Role
Director
Signature
/s/ Joshua L. Colburn, Attorney-in-Fact
Issuer symbol
PBLA
Transactions as of
12 Sep 2023
Transactions value $
$0
Form type
4
Filing time
14 Sep 2023, 17:06:52 UTC
Previous filing
29 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PBLA Common Stock Gift $0 -275 -100% $0.00* 0 12 Sep 2023 Jointly with spouse F1, F2
holding PBLA Common Stock 27 12 Sep 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 216 shares previously held directly and 45 shares previously held by trust that were transferred to joint ownership with spouse on July 31, 2023.
F2 Reflects 1-for-40 reverse stock split that occurred on January 13, 2023 and 1-for-30 reverse split that occurred on June 1, 2023.